Turn Sunshine into Synergy and Unlock Higher Yields Year-round
Optimizing greenhouse production with LED intercanopy lighting has become increasingly relevant, especially in environments characterized by high natural sunlight or strong supplemental toplighting. High-wire crops such as tomatoes often experience a rapid decrease in light levels toward the lower parts of the canopy. When abundant light is supplied from above, either naturally or through toplighting, further increasing upper illumination does not always yield additional benefits. This can result in saturation of the upper leaves while deeper layers receive insufficient light. The challenge is further amplified in lower greenhouse structures, where the proximity between fixtures and crops restricts the effectiveness of toplighting in penetrating the canopy and distributing light uniformly. Consequently, exclusive reliance on toplighting can lead to uneven plant development and reduced yield.
化肥价格上涨给 2026/27 年作物种植计划带来压力。
中东地区的紧张局势正在影响巴西农民的经济状况，并可能进一步增加2026/2027年度粮食收成的成本。这是巴西农业和畜牧业联合会（CNA）本周发布的一项调查得出的结论。
Saku Biosciences bets on tiny “PicoShells” to solve a big biomanufacturing problem
Developing an optimized production host in biomanufacturing takes time and money, two things most startups lack. Saku Bi…
聚力春耕保丰收 先正达嘉丽美®登陆华东 筑牢水稻纹枯病防控防线
世界农化网中文网报道：2026年5月21日，先正达集团水稻专用杀菌剂嘉丽美®华东上市会在浙江绍兴成功举办。本次活动聚焦水稻纹枯病的科学防控，旨在以优质农资赋能春耕生产，为华东地区水稻稳产丰收、保障国家粮食安全注入全新动能。
EU backs Novo Nordisk’s oral Wegovy for weight management
The positive opinion covers the use of Wegovy pill to reduce excess body weight and maintain long-term weight reduction in adults with obesity, or overweight with at least one weight-related comorbidity. According to Novo Nordisk, the opinion also includes data from the SELECT cardiovascular outcomes trial, showing that semaglutide reduces the risk of major adverse cardiovascular events, including cardiovascular death, non-fatal myocardial infarction and non-fatal stroke.
Selecta One With a Strong Showing at the FlowerTrials®
In calendar week 24, Flowers Trials® will once again open its doors to professional visitors from the international horticultural sector. As usual, Selecta will be exhibiting at its site at Kwekerij Bloem & Tuin (Oudecampsweg 4, 2678 KN De Lier, Netherlands) – alongside Evanthia and, for the first time, Morel Cyclamen.
Enzymes Involved in Cholesterol Transport May Point to New Cancer Therapies
Some types of cancer have a relentless appetite for the metabolite cholesterol, using as much as they can access to accelerate their growth beyond the capabilities of normal cells. Research by scientists at Sanford Burnham Prebys Medical Discovery Institute and collaborators at the University of Illinois Chicago have now unveiled a potential method for turning the table on these tumors by subverting their cholesterol cravings.
Regenerative is a bridge to organic production, not a substitute for it, says Friends of the Earth
Not all regenerative certification programs are equal in terms of standards they adhere to and the pesticides they prohi…
OSE’s Tedopi-Keytruda combo clears Phase II ovarian cancer hurdle
The Nantes-based company said the TEDOVA/GINECO-OV244b/ENGOT-ov58 trial met its primary endpoint in patients with platinum-sensitive recurrent ovarian cancer who had progressed after, or were ineligible for, PARP inhibitors and bevacizumab. In the study, Tedopi combined with Keytruda improved median progression-free survival to 4.1 months, compared with 2.8 months for best supportive care.
Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design
The year was 2022. Chris Norn, PhD, was wrapping up his time as a postdoctoral researcher at the Institute for Protein Design (IPD) at University of Washington (UW). AlphaFold was taking the field by storm, while a new generation of deep learning tools was rapidly advancing de novo, or from-scratch, protein design with unprecedented success rates validated at atomic resolution. Within just a few years, these AI breakthroughs, widespread applications across pharmaceuticals, nanomaterials, biosensors, and more, would help earn Norn’s mentor, David Baker, PhD, the Nobel Prize in Chemistry.